- Home
- VRDN vs NFJ Comparison
VRDN vs NFJ Comparison
Compare VRDN & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- NFJ
- Stock Information
- Founded
- VRDN 2006
- NFJ 2005
- Country
- VRDN United States
- NFJ United States
- Employees
- VRDN N/A
- NFJ N/A
- Industry
- VRDN Medical Specialities
- NFJ Finance: Consumer Services
- Sector
- VRDN Health Care
- NFJ Finance
- Exchange
- VRDN Nasdaq
- NFJ Nasdaq
- Market Cap
- VRDN 1.3B
- NFJ 1.2B
- IPO Year
- VRDN N/A
- NFJ N/A
- Fundamental
- Price
- VRDN $15.67
- NFJ $12.60
- Analyst Decision
- VRDN Strong Buy
- NFJ
- Analyst Count
- VRDN 11
- NFJ 0
- Target Price
- VRDN $38.50
- NFJ N/A
- AVG Volume (30 Days)
- VRDN 728.3K
- NFJ 223.5K
- Earning Date
- VRDN 08-07-2025
- NFJ 01-01-0001
- Dividend Yield
- VRDN N/A
- NFJ 9.01%
- EPS Growth
- VRDN N/A
- NFJ N/A
- EPS
- VRDN N/A
- NFJ N/A
- Revenue
- VRDN $302,000.00
- NFJ N/A
- Revenue This Year
- VRDN N/A
- NFJ N/A
- Revenue Next Year
- VRDN $17,102.33
- NFJ N/A
- P/E Ratio
- VRDN N/A
- NFJ N/A
- Revenue Growth
- VRDN 4.86
- NFJ N/A
- 52 Week Low
- VRDN $9.90
- NFJ $10.45
- 52 Week High
- VRDN $27.20
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- VRDN 61.91
- NFJ 69.82
- Support Level
- VRDN $13.84
- NFJ $12.16
- Resistance Level
- VRDN $14.85
- NFJ $12.18
- Average True Range (ATR)
- VRDN 0.82
- NFJ 0.12
- MACD
- VRDN -0.03
- NFJ 0.04
- Stochastic Oscillator
- VRDN 82.81
- NFJ 95.45
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.